⌘K

Login Start Free

Home/Filings/4/0001213900-25-121972

4//SEC Filing

Ence Chuck 4

Accession 0001213900-25-121972

CIK 0001553643other

View on SEC.gov Company Profile

Filed

Dec 15, 7:00 PM ET

Accepted

Dec 16, 9:30 AM ET

Size

5.4 KB

Accession

0001213900-25-121972

Insider Transaction Report

Form 4

Period: 2025-12-12

RELMADA THERAPEUTICS, INC.RLMD

CAO and COO

Transactions

Award
Stock Appreciation Rights
2025-12-12+828,000→ 828,000 total
Exercise: $4.06From: 2026-03-12Exp: 2035-12-12→ Common Stock (828,000 underlying)

Footnotes (1)

[F1]The stock appreciation rights vest in 16 equal quarterly installments commencing on March 12, 2026.

Documents

1 file

4
ownership.xmlPrimary

Issuer

RELMADA THERAPEUTICS, INC.

CIK 0001553643

Entity typeother

Related Parties

1

filerCIK 0001697779

Filing Metadata

Form type: 4
Filed: Dec 15, 7:00 PM ET
Accepted: Dec 16, 9:30 AM ET
Size: 5.4 KB

View on SEC.gov